Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Department of Justice
Cantor Fitzgerald
McKinsey
Cipla
Federal Trade Commission
Argus Health
McKesson
Cerilliant

Generated: May 25, 2018

DrugPatentWatch Database Preview

Ergotamine tartrate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for ergotamine tartrate and what is the scope of ergotamine tartrate patent protection?

Ergotamine tartrate
is the generic ingredient in four branded drugs marketed by 3M, Tersera Theraps Llc, Watson Labs Inc, and Organon Usa Inc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for ergotamine tartrate. Two suppliers are listed for this compound.
Pharmacology for ergotamine tartrate
Ingredient-typeErgotamines
Drug ClassErgotamine Derivative
Synonyms for ergotamine tartrate
(4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
(4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0;{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
(4R,7R)-N-[(1S,2S,4R,7S)-7-BENZYL-2-HYDROXY-4-METHYL-5,8-DIOXO-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),2,9,12,14-PENTAENE-4-CARBOXAMIDE; 2,3-DI
(5''alpha)-12''-hydroxy-2''-methyl-5''-(phenylmethyl)ergotoman-3'',6'',18-trione
(5''alpha)-5''-benzyl-12''-hydroxy-2''-methyl-3'',6'',18-trioxoergotaman
(5'A)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman 2,3-dihydroxybutanedioate(2:1)
(5'alpha)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
(5'alpha)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman
(5|A)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)-ergotaman-3',6',18-trione (2R,3R)-2,3-Dihydroxybutanedioate
1080650-16-3
113-15-5
12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione
12''-hydroxy-2''-methyl-5''alpha-(phenylmethyl)ergotaman-3'',6'',18-trione
379-79-3
379-79-3 (2:1 tartrate salt)
6915-20-4
98260-30-1
AB01275473-01
AC-14836
AC1L1QJJ
AKOS015896505
AKOS015897172
Ambotz113-15-5
Avetol
BDBM50027065
BRN 0078890
C33H35N5O5
C33H35N5O5.C4H6O6
CHEBI:64318
CHEMBL2062265
CHEMBL442
Cornutamin
Cornutamine
D01TSI
D07906
DB00696
DTXSID9043774
EINECS 204-023-9
Ergam
Ergate
Ergomar
Ergomar (TN)
Ergonsvine
Ergostat
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)-
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)-(9CI)
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt)
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
Ergotamin
Ergotamina
Ergotamina [INN-Spanish]
ERGOTAMINE
Ergotamine (INN)
ERGOTAMINE (SEE ALSO: ERGOTAMINE TARTRATE (CAS 379-79-3))
Ergotamine [INN:BAN]
Ergotamine bitartrate
Ergotamine hemitartrate
Ergotamine tartrate (VAN)
Ergotamine tartrate, Avetol, Cornutamin, Ergam, Ergotartrate
Ergotamine, tartrate (2:1)
Ergotamine, tartrate (2:1) (salt) (8CI)
ergotaminum
Ergotaminum [INN-Latin]
Ergotartrate
Ergoton-A
ERM
ETIN
Exmigra
Femergin
Gotamine tartrate
GTPL149
Gynergen
Gynergin
HMS2089H22
HSDB 4076
I06-2464
I07-0341
Lingraine
Lingran
LS-177242
LS-564
Medihaler ergotamine
Migretamine
N-[(2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-methyl-[?]carboxamide
Neo-ergotin
NSC 41869
NSC 95090
PL011604
PR834Q503T
Rigetamin
SCHEMBL1483
SCHEMBL8045
Secagyn
Secupan
Temigran
TX-012337
UNII-PR834Q503T
Wigrettes
ZINC52955754

US Patents and Regulatory Information for ergotamine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc ERGOSTAT ergotamine tartrate TABLET;SUBLINGUAL 088337-001 Jun 8, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
3m MEDIHALER ERGOTAMINE ergotamine tartrate AEROSOL, METERED;INHALATION 012102-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc WIGRETTES ergotamine tartrate TABLET;SUBLINGUAL 086750-001 Jul 29, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Tersera Theraps Llc ERGOMAR ergotamine tartrate TABLET;SUBLINGUAL 087693-001 Feb 24, 1983 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Moodys
McKinsey
Federal Trade Commission
Merck
UBS
Dow
Mallinckrodt
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.